481 related articles for article (PubMed ID: 16280290)
1. Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptor.
Masuo K; Katsuya T; Kawaguchi H; Fu Y; Rakugi H; Ogihara T; Tuck ML
Am J Hypertens; 2005 Nov; 18(11):1508-16. PubMed ID: 16280290
[TBL] [Abstract][Full Text] [Related]
2. beta2- and beta3-Adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals.
Kawaguchi H; Masuo K; Katsuya T; Sugimoto K; Rakugi H; Ogihara T; Tuck ML
Hypertens Res; 2006 Dec; 29(12):951-9. PubMed ID: 17378367
[TBL] [Abstract][Full Text] [Related]
3. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.
Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
Circulation; 2005 Jun; 111(25):3429-34. PubMed ID: 15956122
[TBL] [Abstract][Full Text] [Related]
4. High plasma norepinephrine levels associated with beta2-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals.
Masuo K; Katsuya T; Sugimoto K; Kawaguchi H; Rakugi H; Ogihara T; Tuck ML
Hypertens Res; 2007 Jun; 30(6):503-11. PubMed ID: 17664853
[TBL] [Abstract][Full Text] [Related]
5. Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.
Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
Am J Hypertens; 2005 Jul; 18(7):1009-14. PubMed ID: 16054001
[TBL] [Abstract][Full Text] [Related]
6. Beta2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation.
Masuo K; Katsuya T; Kawaguchi H; Fu Y; Rakugi H; Ogihara T; Tuck ML
Am J Hypertens; 2006 Oct; 19(10):1084-91. PubMed ID: 17027833
[TBL] [Abstract][Full Text] [Related]
7. Sympathetic drive as a determinant of weight loss intervention outcome strengths and limitations.
Grassi G
Am J Hypertens; 2005 Nov; 18(11):1517-8. PubMed ID: 16280291
[No Abstract] [Full Text] [Related]
8. Different mechanisms in weight loss-induced blood pressure reduction between a calorie-restricted diet and exercise.
Masuo K; Rakugi H; Ogihara T; Lambert GW
Hypertens Res; 2012 Jan; 35(1):41-7. PubMed ID: 21814218
[TBL] [Abstract][Full Text] [Related]
9. Relationship between weight loss maintenance and changes in serum leptin levels.
Wing RR; Sinha MK; Considine RV; Lang W; Caro JF
Horm Metab Res; 1996 Dec; 28(12):698-703. PubMed ID: 9013745
[TBL] [Abstract][Full Text] [Related]
10. Interactions among the alpha2-, beta2-, and beta3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study.
Ukkola O; Rankinen T; Weisnagel SJ; Sun G; Pérusse L; Chagnon YC; Després JP; Bouchard C
Metabolism; 2000 Aug; 49(8):1063-70. PubMed ID: 10954027
[TBL] [Abstract][Full Text] [Related]
11. RGS2 C1114G polymorphism and body weight gain in hypertensive patients.
Sartori M; Ceolotto G; Dorigatti F; Mos L; Santonastaso M; Bratti P; Papparella I; Semplicini A; Palatini P;
Metabolism; 2008 Mar; 57(3):421-7. PubMed ID: 18249218
[TBL] [Abstract][Full Text] [Related]
12. Low plasma leptin concentration and low rates of fat oxidation in weight-stable post-obese subjects.
Filozof CM; Murúa C; Sanchez MP; Brailovsky C; Perman M; Gonzalez CD; Ravussin E
Obes Res; 2000 May; 8(3):205-10. PubMed ID: 10832762
[TBL] [Abstract][Full Text] [Related]
13. A nutrigenomic inflammation-related PBMC-based approach to predict the weight-loss regain in obese subjects.
Goyenechea E; Parra D; Crujeiras AB; Abete I; Martínez JA
Ann Nutr Metab; 2009; 54(1):43-51. PubMed ID: 19246894
[TBL] [Abstract][Full Text] [Related]
14. Rise of plasma ghrelin with weight loss is not sustained during weight maintenance.
Garcia JM; Iyer D; Poston WS; Marcelli M; Reeves R; Foreyt J; Balasubramanyam A
Obesity (Silver Spring); 2006 Oct; 14(10):1716-23. PubMed ID: 17062800
[TBL] [Abstract][Full Text] [Related]
15. Effect of significant intermediate-term weight loss on serum leptin levels and body composition in severely obese subjects.
Infanger D; Baldinger R; Branson R; Barbier T; Steffen R; Horber FF
Obes Surg; 2003 Dec; 13(6):879-88. PubMed ID: 14738675
[TBL] [Abstract][Full Text] [Related]
16. Polymorphic variants of the beta2-adrenergic receptor (ADRB2) gene and ADRB2-related propanolol-induced dyslipidemia in the Colombian population.
Isaza C; Henao J; Ramirez E; Cuesta F; Cacabelos R
Methods Find Exp Clin Pharmacol; 2005 May; 27(4):237-44. PubMed ID: 16082424
[TBL] [Abstract][Full Text] [Related]
17. Successful long-term weight maintenance: a 2-year follow-up.
Vogels N; Westerterp-Plantenga MS
Obesity (Silver Spring); 2007 May; 15(5):1258-66. PubMed ID: 17495202
[TBL] [Abstract][Full Text] [Related]
18. Blunted beta-adrenoceptor-mediated fat oxidation in overweight subjects: a role for the hormone-sensitive lipase gene.
Jocken JW; Blaak EE; van der Kallen CJ; van Baak MA; Saris WH
Metabolism; 2008 Mar; 57(3):326-32. PubMed ID: 18249203
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the NPY and AGRP genes and body fatness in Dutch adults.
van Rossum CT; Pijl H; Adan RA; Hoebee B; Seidell JC
Int J Obes (Lond); 2006 Oct; 30(10):1522-8. PubMed ID: 16568137
[TBL] [Abstract][Full Text] [Related]
20. Influence of two polymorphisms of the tumoral necrosis factor-alpha gene on the obesity phenotype.
Corbalán MS; Marti A; Forga L; Patiño A; Martínez-Gonzalez MA; Martínez JA
Diabetes Nutr Metab; 2004 Feb; 17(1):17-22. PubMed ID: 15163120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
